Armine  K. Smith, M.D.
Armine K. Smith, M.D.

Assistant Professor of Urology
Johns Hopkins University School of Medicine

Director of Urologic Oncology
Sibley Memorial Hospital

Address:
Sibley Memorial Hospital Sibley Medical Building 5215 Loughboro Road, N.W. Suite 300 Washington, DC 20016

Appointments:
410-955-6100
202-660-5561

Office: 202-660-5561

Email: asmit165@jhmi.edu

Publications


Free Access to abstracts at PubMed

Peer-reviewed Publications (Selected from 42 peer-reviewed publications)

  1. Jalalizadeh M, Smith AK, Miyamoto H. Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer: Molecular Mechanisms of Action. Clinical Immunology, Endocrine & Metabolic Drugs. 2016 Mar 31. ISSN: 2212-7089
  2. Kerr BA, Miocinovic R, Smith AK, West XZ, Watts KE, Alzayed AW, Klink JC, Mir MC, Sturey T, Hansel DE, Heston WD, Stephenson AJ, Klein EA, Byzova TV. CD117+ cells in the circulation are predictive of advanced prostate cancer. Oncotarget. 2015 Jan 30;6(3):1889-97.
  3. Smith AK, Matin SF, Jarrett TW. Wein: Campbell-Walsh Urology, 11th ed., Chapter 58/Urothelial Tumors of the Upper Urinary Tract and Ureter. Elsevier 2013
  4. Iwai A, Bourboulia D, Mollapour M, Jensen-Taubman S, Lee S, Donnelly AC, Yoshida S, Miyajima N, Tsutsumi S, Smith AK, Sun D, Wu X, Blagg BS, Trepel JB, Stetler-Stevenson WG, Neckers L. Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells. Cell Cycle. 2012 Oct 1;11(19):3649-55.
  5. Smith AK, Stephenson AJ, Lane BR, Larson BT, Thomas AA, Gong MC, Jones SJ, Campbell SC, Hansel DE. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: Implications for conservative management. Urology. 2011 Jul;78(1):82-6.
  6. Kerr BA, Miocinovic R, Smith AK, Klein EA, Byzova TV. Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft model. Neoplasia. 2010 May;12(5):388-96
  7. Lane BR, Smith AK, Larson BT, Gong MC, Campbell SC, Raghavan D, Dreicer R, Hansel DE, Stephenson AJ. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer. 2010 Jun 15;116(12):2967-73.
  8. Chan ESY, Patel AR, Smith AK, Klein JB, Thomas AA, Heston WD, Larchian WA. Optimization of orthotopic bladder tumor implantation in a syngeneic mouse model. J Urol 2009 Dec;182(6):2926-31.
  9. Smith AK, Hansel DE, Klein EA. Epidermoid cyst of the testicle. Urology. 2009 Sep;74(3):544.
  10. Smith AK, Palmer JS: Pediatric robotic urology (Current clinical urology): Chapter 3/Robotic instrumentation and equipment. Humana Press. Sep 9, 2009
  11. Smith AK, Hansel DE, Jones JS: Role of cystitis cystica et glandularis, intestinal metaplasia, and pelvic lipomatosis in development of bladder carcinoma. Urology.2008 May;71(5):915-8.
  12. Greene KL, Elkin EP, Karapetian A, Duchane J, Carroll PR, Kane CJ: Prostate biopsy tumor extent but not location predicts recurrence after radical prostatectomy: results from CaPSURE. J Urol. 2006 Jan;175(1):125-9
  13. Van der Veen RC, Dietlin TA, Karapetian A, Holland SM, Hofman FM: Extra-cellular superoxide promotes T cell expansion through inactivation of nitric oxide. J Neuroimmunol. 2004 Aug;153(1-2):183-9.

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved. Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287

urology second opinion urology second opinion